The global digital therapeutics market is anticipated to witness remarkable growth, with a projected value of USD 41.63 billion by the year 2030. According to recent market analysis, the market size for digital therapeutics was estimated at USD 4.8 billion in 2022, indicating a substantial upward trajectory with a Compound Annual Growth Rate (CAGR) of 31% during the forecast period from 2023 to 2030.
Digital therapeutics, evidence-based software programs designed to treat, manage, or prevent medical conditions, are revolutionizing healthcare by leveraging digital technologies to deliver personalized interventions, improve patient outcomes, and enhance access to care. Key factors driving the growth of the digital therapeutics market include:
Rising Chronic Disease Burden: The escalating prevalence of chronic diseases, including diabetes, hypertension, cardiovascular diseases, mental health disorders, and respiratory conditions, is driving demand for digital therapeutics solutions for disease management, behavior modification, and lifestyle interventions.
Shift Towards Value-Based Care Models: The transition from fee-for-service reimbursement models to value-based care models, focused on improving patient outcomes, reducing healthcare costs, and enhancing patient engagement and adherence, is driving adoption of digital therapeutics as part of comprehensive care management strategies.
Advancements in Digital Health Technologies: Continuous advancements in digital health technologies, including mobile health (mHealth) apps, wearable devices, remote monitoring solutions, artificial intelligence (AI), and machine learning (ML) algorithms, are driving innovation in digital therapeutics platforms and interventions.
Remote Patient Monitoring and Telehealth Integration: The increasing adoption of remote patient monitoring (RPM), telehealth, and virtual care delivery models, particularly in response to the COVID-19 pandemic and the need for remote healthcare access, is driving demand for digital therapeutics solutions for remote patient management and virtual consultations.
Regulatory Approvals and Reimbursement Policies: Growing regulatory approvals and reimbursement policies for digital therapeutics products and services, as demonstrated by the U.S. Food and Drug Administration's (FDA) clearance of prescription digital therapeutics, are driving market growth and adoption by healthcare providers and payers.
Collaborations and Partnerships in Digital Health Ecosystem: Increasing collaborations and partnerships between digital therapeutics companies, pharmaceutical manufacturers, healthcare providers, payers, and technology developers are driving innovation, market expansion, and integration of digital therapeutics into existing healthcare workflows.
KEY MARKET SEGMENTS:
By Sales Channel
- B2C
- Patients
- Caregivers
- B2B
- Providers
- Payers
- Employers
- Pharmaceutical Companies
- Other Buyers
By Application
- Preventive Applications
- Prediabetes
- Obesity
- Nutrition
- Lifestyle Management
- Other Preventive Applications
- Treatment/Care-related Applications
- Diabetes
- CNS Disorders
- Mental Health Disorder
- Other CNS Disorders
- Chronic Respiratory Disorders
- Musculoskeletal Disorders
- Cardiovascular Diseases
- Smoking Cessation
- Medication Adherence
- Gastrointestinal Disorders
- Substance Use & Addiction Management
- Rehabilitation & Patient Care
- Other Treatment/Care-related Applications
The major key players are OMADA HEALTH, INC, Welldoc, Inc, 2Morrow, Inc, Livongo Health, Inc. (Teladoc Health, Inc.), Propeller Health (ResMed), Fitbit LLC, CANARY HEALTH, Noom, Inc, Pear Therapeutics, Inc, Akili Interactive Labs, Inc.
As healthcare stakeholders continue to recognize the potential of digital therapeutics for improving patient outcomes, enhancing healthcare delivery, and addressing unmet medical needs, the digital therapeutics market is expected to witness sustained growth, driven by technological innovation, regulatory support, and expanding applications across diverse therapeutic areas and patient populations.
Other Reports You May Like:
Pharmacy Benefit Management Market Size
About US:
SNS Insider has been a leader in data and analytics globally with its authentic consumer and market insights. The trust of our clients and business partners has always been at the center of who we are as a company. We are a business that leads the industry in innovation, and to support the success of our clients, our highly skilled engineers, consultants, and data scientists have consistently pushed the limits of the industry with innovative methodology and measuring technologies.
We assist our clients to anticipate industrial, economic, and consumer trends to drive disruptive change by fusing global experience with local information from experts throughout the world. We bring context to strategic and tactical data by bridging approaches based on data science and field research, assisting you in addressing your most pressing problems and spotting possibilities.
Contact Us:
Akash Anand – Head of Business Development & Strategy,
info@snsinsider.com,
Phone: +1-415-230-0044 (US) | +91-7798602273 (IND),
Website: https://www.snsinsider.com
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek
